Skip to main content
OpenTrials

Clinical trial condition

Hodgkin Disease

Explore clinical trials studying Hodgkin Disease. Study availability and eligibility vary by location and protocol.

958 public trials 99 recruiting studies
Refine in advanced search Browse all conditions

Hodgkin Disease trial results

Completed

Brentuximab Vedotin in Refractory/Relapsed Hodgkin Lymphoma Treated by ICE

NCT02686346

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +10 more
Locations
  • Clinique Universitaire Saint-Luc Brussels, Belgium
  • CHU Dinant Godinne Yvoir, Belgium
  • Institut d'Hématologie de Basse Normandie - CHU Côte de Nacre Caen, France
  • APHP-Hôpital Henri Mondor Créteil, France
View all 19 locations
View Trial Details
Completed

Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma

NCT01578967

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, Adult, +7 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
  • Levine Cancer Istitute, Carolinas Health Care system Charlotte, North Carolina, United States
View Trial Details
Completed

Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma

NCT01118026

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations
  • Naval Medical Center -San Diego San Diego, California, United States
  • Saint Helena Hospital St. Helena, California, United States
  • Beebe Medical Center Lewes, Delaware, United States
  • Delaware Clinical and Laboratory Physicians PA Newark, Delaware, United States
View all 55 locations
View Trial Details
Completed

Double Cord Versus Haploidentical (BMT CTN 1101)

NCT01597778

Conditions
Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt Lymphoma, +30 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arizona Cancer Center Phoenix, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of California at Los Angeles Los Angeles, California, United States
View all 39 locations
View Trial Details
Completed

Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin Lymphoma

NCT01780662

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +9 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
View all 116 locations
View Trial Details
Completed

Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease

NCT00000626

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +23 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • USC CRS Los Angeles, California, United States
  • Northwestern University CRS Chicago, Illinois, United States
  • Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis, Indiana, United States
View Trial Details

Related conditions